Behavioral therapy in migraine : Expanding the therapeutic arsenal
Mínguez-Olaondo, Ane (Universidad de Deusto)
Días, Patricia Alves (Universidad de Deusto)
de Munáin, Estibaliz López (Hospital del Bidasoa (Hondarribia, Guipúscoa))
Grozeva, Vesselina (Neurology Practice (Sofia, Bulgaria))
Laspra-Solís, Carmen (Clínica Universidad de Navarra)
Villalba, Inés Martín (Hospital Clínic i Provincial de Barcelona)
García-Martín, Valvanuz (Universidad de Deusto)
Vila-Pueyo, Marta (Vall d'Hebron Institut de Recerca (VHIR))
Barandiarán, Myriam (Universidad de Deusto)
Zabalza, Ramon J. (Universidad de Deusto)
Bengoetxea, Ana (Université Libre de Bruxelles)
Universitat Autònoma de Barcelona

Data:	2024
Resum:	The US Headache Consortium developed evidence-based guidelines for the treatment of migraine and found grade A evidence in support of behavior therapy (BT). Understanding the mechanisms of BT may improve the management of migraine and reduce its burden. We performed a narrative review to define the current evidence of BT and determine its usefulness in migraine management. The information was obtained from 116 publications, with 56 of them retrieved through direct searches in PubMed (2011-2020) and the remainder selected by the authors to complete the content. BT might reduce migraine impact by decreasing the sympathetic nervous system's response to stress and increasing pain tolerance. Acting in headache-related surroundings can be improved, together with headache duration and self-efficacy. Applications such as mobile health and electronic health applications can help to carry out healthier lifestyle patterns. Regarding medication overuse, BT seems to be a good choice, with similar results to pharmacological prophylaxis. Advantages of using BT are the lack of adverse effects and the unrestricted use in children, where BT is postulated to be even more effective than the standardized pharmacopeia. BT is an interesting tool that can be used as an add-on therapy in migraine. Through BT, the autonomy and empowerment of migraine patients is enhanced. BT may not cure migraine, but it could help to reduce pain severity perception, disability, and migraine impact, adding an emotive and cognitive approach to the perceptive role of pharmacopeia. Thus, a better approach in migraine, implementing specific therapeutic management, can improve migraine control. Behavior therapy is a useful tool with long-lasting value. Long-term migraine treatment should focus on adherence to therapy as well as on medical information and lifestyle modification options. Data from this study encourage the incorporation of nonpharmacological interventions in migraine treatment and the investigation of these techniques to profile the patient features for which each evaluated technique may be more suitable and thus to obtain a greater return on the investment made while working on it.
Drets:	Aquest document està subjecte a una llicència d'ús Creative Commons. Es permet la reproducció total o parcial, la distribució, la comunicació pública de l'obra i la creació d'obres derivades, fins i tot amb finalitats comercials, sempre i quan es reconegui l'autoria de l'obra original.
Llengua:	Anglès
Document:	Article ; recerca ; Versió publicada
Matèria:	Behavioral ; Disability ; Management ; Migraine ; Therapy
Publicat a:	European Journal of Neurology, Vol. 31 (july 2024) , ISSN 1468-1331

DOI: 10.1111/ene.16414
PMID: 39034641

14 p, 566.7 KB

El registre apareix a les col·leccions:
Articles > Articles de recerca
Articles > Articles publicats